Kit Check
47m
·
EconRx
·
We are beyond excited to welcome AJ Rivosecchi, PharmD onto the podcast to talk about Kit Check. A company that started as a tool for managing hospital medication inventory is growing to address drug diversion and spend optimization. Along the way they may even change industry standards for the pharmaceutical industry.
email: [email protected]
Twitter/Instagram: @EconRx
LinkedIn: www.linkedin.com/company/econrx
Website: https://econrx.libsyn.com/
kitcheck.com
The episode Kit Check from the podcast EconRx has a duration of
47:51. It was first published
More episodes from EconRx
Alzheimer's Boom or Bust
Aducanumab (brand name Aduhelm) drew headlines when it was approved by the FDA in 2021 against the recommendations of the FDA advisory committee. Today it's almost commercially dead. On this episode are joined by P4 student Ise Brockmann to dive into aducanumab's story.
email: [email protected]
Twitter/Instagram: @EconRx
LinkedIn: www.linkedin.com/company/econrx
Website: https://econrx.libsyn.com/
$35 Insulin Cap
Capping patient out-of-pocket costs for insulin has been a popular move for legislators, most recently by the US House. On this episode we weigh the Pros, Cons, and viral reactions to this move including lowering vs. shifting costs, ADA guidelines, and political theater.
email: [email protected]
Twitter/Instagram: @EconRx
LinkedIn: www.linkedin.com/company/econrx
Website: https://econrx.libsyn.com/
Testing Woes & Ivermectin
After explaining a HORRENDOUS mistake made recently by the NABP and the oversight of NAPLEX testing that affected one of our own, we decided it's high time we dove into the controversy around the use of ivermectin against COVID-19. Social media and mainstream news can be confusing, so we tried to summarize while sticking to what is known. If we missed something, please let us know!
email: [email protected]
Twitter/Instagram: @EconRx
LinkedIn: www.linkedin.com/company/econrx
Website: https://econrx.libsyn.com/
Blueberry Pharmacy
On this episode we were blessed to have on Kyle McCormick, owner/operator of Blueberry Pharmacy, to explain his unique (but traditionally familiar) business model. Blueberry operates on a cost-plus model and DOES NOT ACCEPT INSURANCE. Crazy? Maybe not. Kyle explains why he thinks we need different payment systems for cheap generics than expensive brand names, circumventing PBMs when they aren't necessary.
https://blueberrypharmacy.com/
email: [email protected]
Twitter/Instagram: @EconRx
LinkedIn: www.linkedin.com/company/econrx
Website: https://econrx.libsyn.com/
[NEWSFLASH] Amazon: Usual & Customary
The Twittersphere recently noticed that quoted savings on Amazon Pharmacy are a little bit unrealistic. On this episode we break down how a pharmacy's "Usual & Customary" price SHOULD be calculated, what it is used for, and what Amazon's crazy numbers say about their pharmacy business model.
email: [email protected]
Twitter/Instagram: @EconRx
LinkedIn: www.linkedin.com/company/econrx
Website: https://econrx.libsyn.com/